GU Oncology Now (@GUOncologyNow) / X

GU Oncology Now

2,710 posts

GU Oncology Now

@GUOncologyNow

GU Oncology Now brings you the latest research and updates in #prostatecancer, #bladdercancer, #kidneycancer, and more in the genitourinary oncology sphere.

Joined October 2021

GU Oncology Now
@GUOncologyNow
Feb 10, 2023
GU Oncology Now spoke with Jonathan A. Coleman, MD, an attending surgeon and urology specialist at @MSKCancerCenter on his unique career path, his role in helping define #UTUC as a unique disease, and his research to improve patient outcomes. Read more: buff.ly/3Ibazgc
7.5K
GU Oncology Now
@GUOncologyNow
Oct 15, 2024
🧠@DrChoueiri looks forward to experts in the advanced #bladdercancer and #kidneycancer fields putting their heads together to brainstorm about guidelines and best practices for community cancer treatment at #AUC3 on January 23-24 2025 in #Miami. 🧠#AUC3 will provide the
00:00
3.4K
GU Oncology Now
@GUOncologyNow
Apr 18, 2023
The @Uromigos spoke with @KidneyCancerDoc and @DrChoueiri on the use of belzutifan in recent studies and how the drug can work alone or in combination with other treatments for patients with early and late-stage renal cancer. Listen now: buff.ly/3A6WZp9
7.4K
GU Oncology Now
@GUOncologyNow
Feb 17, 2023
Coming soon: @brian_rini moderates an exciting #kidneycancer roundtable discussion featuring @montypal, @ShuchiGulati, and @MosheOrnsteinMD! #GU23
4.3K
GU Oncology Now
@GUOncologyNow
Jul 20, 2023
What are the novel biomarkers being developed in #kidneycancer and how can they be used together? @DrRanaMcKay and @BraunMDPhD speculate on the role that #ArtificialIntelligence will likely play...bit.ly/3Q54ead @UCSanDiego @YaleCancer
00:00
3.8K
GU Oncology Now
@GUOncologyNow
Nov 4, 2023
Mike Atkins has arrived to a round of applause at #UromigosLive for his lifetime achievement award!
00:00
7.4K
GU Oncology Now
@GUOncologyNow
Jan 30, 2024
Dr. Regina Barragán-Carrillo (@ReginaBarCar) provided an overview of her research on the difference between treatment with #nivolumab and #ipilimumab versus extract from the comestible camu camu berry in patients with #mRCC. Learn More: buff.ly/3HAKLca
00:00
21K
GU Oncology Now
@GUOncologyNow
Nov 4, 2023
That's a wrap on the fantastic rising stars panel at #UromigosLive! Give it up for @PBarataMD, @bergsa83, @anis_a_hamid, @AmandaNizamMD, and @DrKarineTawagi!
12K
GU Oncology Now
@GUOncologyNow
Jan 12, 2023
We spoke with Dr. Alexander Kutikov (@uretericbud), chair of the Department of Urology at the Fox Chase Cancer Center (@FCUroOnc @FoxChaseCancer), on the innovations he has pioneered in the GU surgical landscape. Read this exclusive interview here: buff.ly/3GXgd4H
2.7K
GU Oncology Now
@GUOncologyNow
Oct 10, 2024
🎓From #ESMO24 @myESMO Presidential Symposium to @Uromigos #UromigosLive24, @tompowles1 shares an exclusive look with @GUOncologyNow into his groundbreaking #NIAGARA trial in #MIBC, which proved ⬆️ OS and EFS when #durvalumab was added to the SOC regimen. 👀Dr. Powles shares
00:00
5.1K
GU Oncology Now
@GUOncologyNow
Sep 4, 2024
👀 @katy_beckermann previews various clinical trials and studies to be presented at #ESMO24, including those on #immunotherapy for #metastatic #KidneyCancer. 👉 Watch Now: buff.ly/4e81vFS
00:00
2K
GU Oncology Now
@GUOncologyNow
Nov 21, 2024
⭐ In our new star-studded roundtable, Drs. @katy_beckermann, @montypal, @DrChoueiri, @HHammersMD, and @PBarataMD discuss ICIs, TKIs, and more treatments in the #RCC landscape. 📺 Learn about the the TiNivo-2 and CONTACT-3 trials in part one: buff.ly/3Zkg6bF
00:00
2.8K
GU Oncology Now
@GUOncologyNow
May 19, 2023
We interviewed @DrRosenbergMSK on the data that led to the @US_FDA's accelerated approval of enfortumab vedotin in combination with pembrolizumab for patients with locally advanced or metastatic urothelial carcinoma. Watch now: buff.ly/45qBRsz
2.7K
GU Oncology Now
@GUOncologyNow
Oct 14, 2024
We've been preparing the #UromigosLive24 sessions into bite-sized segments. Here's the first four-part series on peri-operative therapy in #bladdercancer moderated by @tompowles1 with panelists @apolo_andrea @shilpaonc @kalasri3 and @PGrivasMDPhD. 👉Part 1: NIAGARA Trial for
2.6K